Schedule 13G ownership disclosure
AEON BIOPHARMA INC
Common Stock · CUSIP: 00791X209
Event date: 2025-02-28
- Filing-level shares
- 629,614.00
- Percent of class
- 6.23%
- Alta Partners LLC
Shares: 629,614.00 · Class: 6.23%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-021962
- Form type
- SCHEDULE 13G
- Filer
- AEON Biopharma, Inc.
- CIK
- CIK 1837607
- Filed
- Mar 10, 2025
- Reporting period
- Feb 28, 2025
- Description
- Schedule 13G beneficial ownership